Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline-Reference-Cited by-同舟云学术

Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline

Published:2021-04-30 Issue:3 Volume:9 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Dashwood Alexander¹²^ORCID,Cheesman Elizabeth²^ORCID,Wong Yee Weng¹²^ORCID,Haqqani Haris¹²^ORCID,Beard Nicole³⁴^ORCID,Hay Karen⁵^ORCID,Spratt Melanie¹²³,Chan Wandy¹²,Molenaar Peter¹²³^ORCID

Affiliation:

1. Heart Lung Institute The Prince Charles Hospital Chermside QLD Australia

2. Cardio‐Vascular Molecular & Therapeutics Translational Research Group University of Queensland Brisbane QLD Australia

3. Queensland University of Technology Brisbane Australia

4. Faculty of Science and Technology University of Canberra Canberra ACT Australia

5. QIMR Berghofer Medical Research Institute Brisbane QLD Australia

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.760

Reference44 articles.

1. Cardiac Calcitropes, Myotropes, and Mitotropes

2. Cardiac inotropes: current agents and future directions

3. Mechanisms and Use of Calcium-Sensitizing Agents in the Failing Heart

4. Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure

5. Mechanistic and structural basis for activation of cardiac myosin force production by omecamtiv mecarbil

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maturation of human cardiac organoids enables complex disease modelling and drug discovery;2024-09-09

2. Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future;Frontiers in Cardiovascular Medicine;2024-03-19

3. Danicamtiv increases myosin recruitment and alters the chemomechanical cross bridge cycle in cardiac muscle;2023-02-03

4. Effects of omecamtiv mecarbil and mavacamten in isolated human atrium;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-11-18

5. Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-11-01